InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

ARGENX SE

ARGX Clue Score41
Netherlands Fiscal year ends December CIK 0001697862
$802.64 -1.19% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $802.64 +171.62% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 18 May 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue14.7Fiscal year 2017Revenue36.4 +147.5%Net income−28.1Fiscal year 2018Revenue21.5 −41.0%Operating income−81.8Net income−66.6Fiscal year 2019Revenue69.8 +224.8%Operating income−198.9Net income−163.0EPS, diluted−4.69Fiscal year 2020Revenue36.4 −47.8%Operating income−477.6Net income−608.5EPS, diluted−13.40Fiscal year 2021Operating income−348.7Net income−408.3EPS, diluted−7.99Fiscal year 2022Operating income−720.3Net income−709.6EPS, diluted−13.05Fiscal year 2023Operating income−425.0Net income−295.1EPS, diluted−5.16Fiscal year 2024Operating income−21.7Net income833.0EPS, diluted12.78Fiscal year 2025Operating income1,053.8Net income1,292.0 +55.1%EPS, diluted19.57 +53.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 14.7 36.4 21.5 69.8 36.4 n/a n/a n/a n/a n/a
Growth +147.5% −41.0% +224.8% −47.8%
Operating income n/a n/a −81.8 −198.9 −477.6 −348.7 −720.3 −425.0 −21.7 1,053.8
Net income n/a −28.1 −66.6 −163.0 −608.5 −408.3 −709.6 −295.1 833.0 1,292.0
Growth +55.1%
EPS, diluted n/a n/a n/a −4.69 −13.40 −7.99 −13.05 −5.16 12.78 19.57
Growth +53.1%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Net margin−77.1%Fiscal year 2018Operating margin−381.0%Net margin−310.2%Fiscal year 2019Operating margin−285.0%Net margin−233.5%Free cash flow margin214.7%Fiscal year 2020Operating margin−1,311.2%Net margin−1,670.4%Free cash flow margin−1,096.9%Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a −381.0% −285.0% −1,311.2% n/a n/a n/a n/a n/a
Net margin n/a −77.1% −310.2% −233.5% −1,670.4% n/a n/a n/a n/a n/a
Free cash flow margin n/a n/a n/a 214.7% −1,096.9% n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Operating cash flow151.6Capital expenditure−1.8Free cash flow149.8Fiscal year 2020Operating cash flow−398.5Capital expenditure−1.1Free cash flow−399.5 −366.6%Fiscal year 2021Operating cash flow−606.8Capital expenditure−3.6Free cash flow−610.4Fiscal year 2022Operating cash flow−862.8Capital expenditure−0.8Free cash flow−863.6Fiscal year 2023Operating cash flow−420.3Capital expenditure−0.8Free cash flow−421.1Fiscal year 2024Operating cash flow−82.7Capital expenditure−1.8Free cash flow−84.5Fiscal year 2025Operating cash flow685.2Capital expenditure−6.2Free cash flow679.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow n/a n/a n/a 151.6 −398.5 −606.8 −862.8 −420.3 −82.7 685.2
Capital expenditure n/a n/a n/a −1.8 −1.1 −3.6 −0.8 −0.8 −1.8 −6.2
Free cash flow n/a n/a n/a 149.8 −399.5 −610.4 −863.6 −421.1 −84.5 679.0
Growth −366.6%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2016Fiscal year 2017Fiscal year 2018Cash and securities321.8Shareholders’ equity616.5Fiscal year 2019Cash and securities372.2Shareholders’ equity1,180.4Fiscal year 2020Cash and securities1,216.8Shareholders’ equity1,674.1Fiscal year 2021Cash and securities1,334.7Shareholders’ equity2,534.2Fiscal year 2022Cash and securities800.7Shareholders’ equity2,813.7Fiscal year 2023Cash and securities2,048.8Shareholders’ equity4,097.5Fiscal year 2024Cash and securities1,499.9Shareholders’ equity5,498.3Fiscal year 2025Cash and securities3,491.3Shareholders’ equity7,323.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and securities n/a n/a 321.8 372.2 1,216.8 1,334.7 800.7 2,048.8 1,499.9 3,491.3
Shareholders’ equity n/a n/a 616.5 1,180.4 1,674.1 2,534.2 2,813.7 4,097.5 5,498.3 7,323.1

In millions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of EUR, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
14.7 36.4 21.5 69.8 36.4 n/a n/a n/a n/a n/a
Growth +147.5% −41.0% +224.8% −47.8%
n/a n/a n/a n/a n/a n/a 29.4 117.8 227.3 450.7
n/a n/a 83.6 220.8 370.9 580.5 663.4 859.5 983.4 1,364.1
n/a n/a n/a 72.1 171.6 307.6 472.1 711.9 1,055.3 1,367.1
n/a n/a −81.8 −198.9 −477.6 −348.7 −720.3 −425.0 −21.7 1,053.8
Growth
n/a n/a n/a −175.9 −605.4 −399.7 −729.3 −304.5 85.2 1,278.6
n/a n/a n/a 5.3 3.1 8.5 −19.7 −9.4 −747.9 −13.4
n/a −28.1 −66.6 −163.0 −608.5 −408.3 −709.6 −295.1 833.0 1,292.0
Growth +55.1%
Per share
n/a n/a n/a −4.69 −13.40 −7.99 −13.05 −5.16 13.92 21.08
n/a n/a n/a −4.69 −13.40 −7.99 −13.05 −5.16 12.78 19.57
Growth +53.1%
18.8 24.6 33.4 38.6 45.4 51.1 54.4 57.2 59.9 61.3
n/a n/a n/a n/a n/a n/a 54.4 57.2 65.2 66.0
Growth +5.1% +14.0% +1.3%

Shown in EUR as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 7 of 9 years on file.